Clinical Trials Directory

Trials / Completed

CompletedNCT06096376

Predictors of HFNC Failure in Patients With AHRF Using Diaphragm Ultrasound

Predictors of High-Flow Nasal Cannula Failure (HFNC) in Patients With Acute Hypoxemic Respiratory Failure (AHRF) Using Diaphragm Ultrasound Parameters

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Queen Mary Hospital, Hong Kong · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Ultrasound of the diaphragm is an easily reproducible bedside tool that provides a non-invasive measurement of inspiratory muscle function and respiratory efficiency. The diaphragmatic thickness correlates with the strength and muscle shortening and is reflective of its contribution to the respiratory workload. Diaphragm thickening fraction (DTF) has been shown to be predictive of extubation failure in ventilated patients. However, whether measurements of DTF are predictive of high flow nasal cannula (HFNC) outcomes in patients with acute hypoxemic respiratory failure (AHRF) remains unknown. The objective of this study is to identify predictors of HFNC failure by diaphragm ultrasound and to compare its performance with the well-established ROX index.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiaphragm UltrasoundDiaphragm ultrasound to assess respiratory muscle function and respiratory efficiency

Timeline

Start date
2023-04-28
Primary completion
2024-06-26
Completion
2024-09-01
First posted
2023-10-23
Last updated
2024-10-17

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06096376. Inclusion in this directory is not an endorsement.